NCT04021719

Brief Summary

This application proposes OnTrackNY as a regional scientific hub for the Early Psychosis Intervention Network (EPINET) program as part of the National Institute of Mental Health (NIMH)'s creation of a national learning health care system (LHS) for early psychosis care. OnTrackNY has grown into a 22-site network, under the leadership of Lisa Dixon, MD, MPH. Created and supported by the New York State's Office of Mental Health (OMH), OnTrackNY is a nationally recognized model providing coordinated specialty care (CSC) for adolescents and young adults within two years of the onset of non-affective psychosis. OMH regulates and licenses all mental health programs in New York and is a direct-services provider via state-operated programs statewide. This makes OMH an ideal partner for establishing a statewide learning health care system for early psychosis care. Further, OnTrackNY's administration, OnTrackCentral, operates within the OMH-supported Center for Practice Innovations at Columbia Psychiatry. In this model, OnTrackCentral serves as the hub and the 22 OnTrackNY programs serve as the spokes. Since 2014, the still-growing OnTrackNY network has served over 1,600 individuals. From its inception, OnTrackNY has aimed to deliver high-quality, data-driven, accountable and culturally competent care consistent with an LHS. As a condition of funding, all OnTrackNY providers follow established protocols that require submission of patient- and site-level standard measures of early psychosis clinical features, services, and treatment outcomes. The proposed EPINET regional hub, the OnTrackNY LHS, will emphasize and enhance two critical foundational components - Aim 1: proactively engage stakeholders to optimize understanding of key problems and their solutions at every LHS phase; and Aim 2: develop data systems with enhanced standardized data collection, including post-discharge data and linkages to external data systems, and enhancing data analytics that will allow for client-level treatment planning and prospective analytics, delivering real time, dynamic and actionable information to stakeholders. These LHS components do not follow in a stepwise sequence but instead operate in parallel and interact to facilitate and enhance quality improvement processes. This backbone will support the development of practice-based research.

Trial Health

53
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial recruitment is currently suspended
Enrollment
2,100

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started Aug 2019

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress91%
Aug 2019Dec 2026

First Submitted

Initial submission to the registry

July 11, 2019

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 16, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

August 15, 2019

Completed
7.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Last Updated

February 4, 2026

Status Verified

February 1, 2026

Enrollment Period

7.4 years

First QC Date

July 11, 2019

Last Update Submit

February 2, 2026

Conditions

Keywords

First Episode PsychosisLearning Healthcare systemStakeholdersData infrastructurePsychotic disordersMental disordersSchizophrenia Spectrum and Other Psychotic Disorders

Outcome Measures

Primary Outcomes (3)

  • Participation in work and school

    Participation in competitive employment and/or degree-based education program, as assessed in OnTrackNY assessment instruments

    Up to 5 years

  • MIRECC GAF occupational, social and symptom functioning

    Improvements in occupational, symptom and social functioning, as measured by the MIRECC Global Assessment of Functioning (GAF) scores

    Up to 5 years

  • Hospitalization rates

    Decreases in rates of psychiatric hospitalization per quarter, as assessed in OnTrackNY assessment instruments

    Up to 5 years

Study Arms (1)

OnTrackNY LHS Participants and Stakeholders

OnTrackNY participants and stakeholders, including past participants, family members, clinicians, administrators, payors, and state leadership

Other: Stakeholder feedbackOther: Data infrastructure

Interventions

Data will be systematically collected as part of CQI activities, within a state-of-the-art data infrastructure that allows for client-level feedback to clients, providers and sites to improve quality of care.

OnTrackNY LHS Participants and Stakeholders

Stakeholders, including OnTrackNY participants, past participants, family members, clinicians, administrators, payors and state leadership, will participate in a variety of activities to provide continuous quality improvement to the OnTrackNY program, including a Stakeholder Workgroup, interviews and focus groups

OnTrackNY LHS Participants and Stakeholders

Eligibility Criteria

Age16 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

OnTrackNY participants at an OnTrackNY site (currently 28 sites statewide) or other stakeholders.

You may qualify if:

  • OnTrackNY participants are individuals age 16-30 who have experienced non-affective psychoses for less than two years and have enrolled at an OnTrackNY site. Other stakeholders include past OnTrackNY participants, family members, clinicians, administrators, payors and agency leadership.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

OnTrackNY Central

New York, New York, 10032, United States

Location

Related Publications (2)

  • Patel SR, Bello I, Cabassa LJ, Nossel IR, Wall MM, Montague E, Rahim R, Mathai CM, Dixon LB. Adapting coordinated specialty care in the post-COVID-19 era: study protocol for an integrative mixed-methods study. Implement Sci Commun. 2021 Jul 5;2(1):72. doi: 10.1186/s43058-021-00178-x.

  • Patel S, Bello I, Cabassa LJ, Nossel IR, Wall MM, Montague E, Rahim R, Mathai CM, Dixon LB. Adapting Coordinated Specialty Care in the Post-COVID-19 Era: Study Protocol for an Integrative Mixed-methods Study. Res Sq [Preprint]. 2021 Apr 26:rs.3.rs-452200. doi: 10.21203/rs.3.rs-452200/v1.

MeSH Terms

Conditions

Psychotic DisordersMental DisordersSchizophrenia Spectrum and Other Psychotic Disorders

Study Officials

  • Lisa B Dixon, MD, MPH

    New York State Psychiatric Institute

    PRINCIPAL INVESTIGATOR
  • Iruma Bello, PhD

    New York State Psychiatric Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
OTHER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

July 11, 2019

First Posted

July 16, 2019

Study Start

August 15, 2019

Primary Completion (Estimated)

December 30, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

February 4, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

Locations